2018
Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors
Strosberg D, Schneider EB, Onesti J, Saunders N, Konda B, Shah M, Dillhoff M, Schmidt CR, Shirley LA. Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors. Annals Of Surgical Oncology 2018, 25: 3613-3620. PMID: 30182331, DOI: 10.1245/s10434-018-6741-x.Peer-Reviewed Original ResearchConceptsRepeat transarterial chemoembolizationMetastatic neuroendocrine tumorsTransarterial chemoembolizationPancreastatin levelsNeuroendocrine tumorsOverall survivalPrognostic impactImproved overall survivalProgressive liver diseaseFirst transarterial chemoembolizationWorse overall survivalUseful prognostic indicatorLong-term survivalPg/mLConclusionsFor patientsPost TACECarcinoid syndromeTACE treatmentLiver metastasesPatient demographicsImproved survivalLiver diseasePoor outcomePrognostic indicatorResultsA total
2017
Intraoperative cholangiography during cholecystectomy among hospitalized medicare beneficiaries with non-neoplastic biliary disease
Lilley EJ, Scott JW, Jiang W, Krasnova A, Raol N, Changoor N, Salim A, Haider AH, Weissman JS, Schneider EB, Cooper Z. Intraoperative cholangiography during cholecystectomy among hospitalized medicare beneficiaries with non-neoplastic biliary disease. The American Journal Of Surgery 2017, 214: 682-686. PMID: 28669532, DOI: 10.1016/j.amjsurg.2017.06.021.Peer-Reviewed Original ResearchConceptsCBD injuryIntraoperative cholangiographyBiliary diseaseInpatient cholecystectomyMedicare beneficiariesCommon bile duct injuryBile duct injuryMultivariable logistic regressionHazard of deathHospitalized Medicare beneficiariesNon-neoplastic indicationsGallbladder obstructionDuct injuryCox regressionRetrospective studyCholecystectomyHigh riskPatientsInjuryLogistic regressionConfirmatory testDiseaseCholangiographySelective useSurvival
2016
Predictors of improved survival for patients with retroperitoneal sarcoma
Giuliano K, Nagarajan N, Canner JK, Wolfgang CL, Bivalacqua T, Terezakis S, Herman J, Schneider EB, Ahuja N. Predictors of improved survival for patients with retroperitoneal sarcoma. Surgery 2016, 160: 1628-1635. PMID: 27495850, DOI: 10.1016/j.surg.2016.05.041.Peer-Reviewed Original ResearchConceptsRetroperitoneal sarcomaMultivariable survival analysisSurvival analysisRetroperitoneal sarcoma patientsEnd Results (SEER) databaseOperative resectionImproved survivalLymph nodesSurvival benefitDistant metastasisHistologic typeResults databaseSarcoma patientsRare tumorCancer DatabaseLonger survivalPatientsSarcomaSurvivalParametric survival functionsLocal extensionFurther studiesHigh rateResectionRecurrenceA novel score to estimate the risk of pneumonia after cardiac surgery
Kilic A, Ohkuma R, Grimm J, Magruder J, Sussman M, Schneider E, Whitman G. A novel score to estimate the risk of pneumonia after cardiac surgery. Journal Of Thoracic And Cardiovascular Surgery 2016, 151: 1415-1421. PMID: 27085620, DOI: 10.1016/j.jtcvs.2015.12.049.Peer-Reviewed Original ResearchMeSH KeywordsAge DistributionAgedCardiac Surgical ProceduresCardiopulmonary BypassCohort StudiesFemaleHumansIncidenceMaleMiddle AgedMultivariate AnalysisPneumoniaPostoperative ComplicationsRegression AnalysisRetrospective StudiesRisk FactorsSeverity of Illness IndexSex DistributionSurvival RateUnited StatesConceptsCardiac surgeryPostoperative pneumoniaRisk scoreValidation cohortRisk factorsMultivariable modelRate of pneumoniaRisk of pneumoniaSingle-institution databaseSignificant risk factorsComposite scoreIntraoperative predictorsPerioperative managementPrimary outcomeTraining cohortPneumoniaSurgeryNovel scorePreventative interventionsCohortOverall rateScoresPatientsSignificant correlationRegression analysis
2015
Trends in Incident Hemodialysis Access and Mortality
Malas MB, Canner JK, Hicks CW, Arhuidese IJ, Zarkowsky DS, Qazi U, Schneider EB, Black JH, Segev DL, Freischlag JA. Trends in Incident Hemodialysis Access and Mortality. JAMA Surgery 2015, 150: 441-448. PMID: 25738981, DOI: 10.1001/jamasurg.2014.3484.Peer-Reviewed Original ResearchConceptsEnd-stage renal diseaseHemodialysis cathetersArteriovenous fistulaArteriovenous graftsLower mortalityRenal diseaseVascular accessHD outcomesNational Kidney Foundation Kidney Disease Outcomes Quality InitiativeKidney Foundation Kidney Disease Outcomes Quality InitiativeMultivariable Cox proportional hazards modelsPrior renal replacement therapyUS Renal Data SystemCox proportional hazards modelArteriovenous fistula useIncident HD patientsInitiation of hemodialysisRetrospective cohort studyRenal replacement therapyProportional hazards modelFistula useCohort studySurvival benefitHD patientsPropensity score-matching technique
2013
Influence of Patient, Physician, and Hospital Factors on 30-Day Readmission Following Pancreatoduodenectomy in the United States
Hyder O, Dodson R, Nathan H, Schneider E, Weiss M, Cameron J, Choti M, Makary M, Hirose K, Wolfgang C, Herman J, Pawlik T. Influence of Patient, Physician, and Hospital Factors on 30-Day Readmission Following Pancreatoduodenectomy in the United States. JAMA Surgery 2013, 148: 1095-1102. PMID: 24108580, PMCID: PMC3983984, DOI: 10.1001/jamasurg.2013.2509.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAttitude of Health PersonnelCohort StudiesComorbidityCross InfectionFemaleHealth Care SurveysHospital MortalityHumansLength of StayMaleMedicareOutcome Assessment, Health CarePancreatic NeoplasmsPancreaticoduodenectomyPatient ReadmissionPostoperative ComplicationsPractice Patterns, Physicians'Retrospective StudiesRisk FactorsSEER ProgramSurvival RateTime FactorsUnited StatesWorkloadConceptsPancreatoduodenectomy proceduresMedical comorbiditiesHospital factorsSurgeon volumeMedicare dataPopulation-based cancer registry dataPreoperative medical comorbiditiesRetrospective cohort studyDays of dischargeHospital-level factorsLow-volume hospitalsPatient-related factorsChance of readmissionLength of stayInfluence of patientCancer registry dataPancreatoduodenectomy patientsHospital morbidityCohort studyHospital volumeHospital readmissionMedian agePhysician factorsDistinct hospitalsPatient level
2012
Influence of the National Trauma Data Bank on the Study of Trauma Outcomes: Is It Time to Set Research Best Practices to Further Enhance Its Impact?
Haider A, Saleem T, Leow J, Villegas C, Kisat M, Schneider E, Haut E, Stevens K, Cornwell E, MacKenzie E, Efron D. Influence of the National Trauma Data Bank on the Study of Trauma Outcomes: Is It Time to Set Research Best Practices to Further Enhance Its Impact? Journal Of The American College Of Surgeons 2012, 214: 756-768. PMID: 22321521, PMCID: PMC3334459, DOI: 10.1016/j.jamcollsurg.2011.12.013.Peer-Reviewed Original Research
2011
Differential Association of Race With Treatment and Outcomes in Medicare Patients Undergoing Diverticulitis Surgery
Schneider EB, Haider A, Sheer AJ, Hambridge HL, Chang DC, Segal JB, Wu AW, Lidor AO. Differential Association of Race With Treatment and Outcomes in Medicare Patients Undergoing Diverticulitis Surgery. JAMA Surgery 2011, 146: 1272-1276. PMID: 22106319, DOI: 10.1001/archsurg.2011.280.Peer-Reviewed Original ResearchConceptsMedical comorbiditiesInsurance statusUrgent/emergency surgeryGreater riskRacial disparitiesUrgent/emergencyMedicare Provider AnalysisHealth insurance statusObserved racial disparitiesHospital mortalityGreater comorbidityEmergency surgerySurgical treatmentEmergency admissionsStudy criteriaBlack raceWorse outcomesMedicare patientsProcedure typeRetrospective analysisInpatient dataComorbiditiesMortality riskMultivariable regressionOutcome data